Walleye Trading’s Albany Molecular Research Inc AMRI Stock Holding History

Walleye Trading’s Portfolio AMRI Stock Details AMRI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-60,117	Closed	-$1.3K	–	4921
2017 Q2	$1.3K	Buy	+60,117	New	+$1.09M	0.01%	1530
2016 Q1	–	Sell	-9,101	Closed	-$143K	–	6165
2015 Q4	$181K	Buy	9,101 +8,455	+1,309%	+$161K	﹤0.01%	2793
2015 Q3	$11K	Buy	+646	New	+$13.2K	﹤0.01%	4368
2014 Q4	–	Sell	-2,910	Closed	-$53.4K	–	4710
2014 Q3	$64K	Buy	+2,910	New	+$59.6K	﹤0.01%	2969
2014 Q1	–	Sell	-55	Closed	-$757	–	4139
2013 Q4	$1K	Buy	+55	New	+$665	﹤0.01%	3581

Other funds holding AMRI

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Walleye Trading's AMRI Position: Q3 2017 in Review

Walleye Trading sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 60,117 shares — an estimated $1.3K sold.

Walleye Trading first reported a position in AMRI in Q4 2013 and held it in 5 quarters. The position peaked at $181K in Q4 2015. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

Walleye Trading reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
Walleye Trading sold 60,117 Albany Molecular Research Inc shares in Q3 2017, an estimated $1.3K.
Walleye Trading first reported a position in Albany Molecular Research Inc in Q4 2013 and held it in 5 quarters.
Walleye Trading's Albany Molecular Research Inc position peaked at $181K in Q4 2015.
2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Walleye Trading's 13F filing for Q3 2017, filed 14 Nov 2017.